Since marijuana is illegal on a federal level, but legal on a state-by-state basis, growers and cannabis businesses cannot legally transport cannabis products across state lines. Some companies that make CBD products — usually supplied in the form of lotion, oils, and pills — have done so anyway, based on the claim that CBD derived from hemp can be classified as botanical extract and a dietary supplement. But over the past few years, the FDA has issued numerous “cease and desist” letters to companies produce cannabis products warning them not to make health-related CBD claims and making clear that it does not consider CBD a dietary supplement.
There seems to be a good amount of misunderstanding about how the passage of the Agriculture Improvement Act of 2018 (or the “2018 Farm Bill”) affects the legality of selling industrial hemp-derived CBD products. But to reiterate, nothing in the 2018 Farm Bill alters the FDA’s position on CBD pursuant to the Federal Food, Drug, and Cosmetic Act (FDCA). Here are some additional highlights from that statement:
As Vox’s German Lopez notes, the move toward hemp legalization is less about removing the stigma of cannabis than about the economic benefits of legalizing marijuana. Hemp’s legalization will give farmers a major opportunity with a new and friendly crop. According to Leafly, the hemp plant “detoxifies the soil and prevents soil erosion,” and it “requires much less water to grow — and no pesticides — so it is much more environmentally friendly than traditional crops.”
The manufacturer will probably give you a recommended dosage, but bear in mind that this isn’t set in stone. What you need to find is your own minimum effective dose. “Minimum effective dose” is a medical term which refers to the amount of a substance you need for the results you want, and above which, the substance doesn’t increase in effectiveness.
Flower Power, which sells CBD-infused coffee to cafes like Caffeine Underground in New York City, puts 5 mg of CBD in each serving of coffee. The company, like many involved in the sale of CBD, is extremely careful about what it says regarding CBD’s effects for fear of FDA intervention. The standard language for CBD packaging and website documentation is similar to that of many supplements (think: milk thistle, echinacea, elderberry, turmeric) and is some variation on: “These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease or ailment.”
During one study, 10 healthy male participants took just one 600 mg dose of CBD oil. Their resting blood pressure went down successfully. These same men were then put on stress tests. These tests were specifically designed to raise blood pressure. After taking the same dose of CBD, the men yielded positive results. Their blood pressure was lower than it normally would be in these stressful situations. Most scientists agreed that CBD lowers blood pressure because of its ability to help reduce anxiety and stress.
Selective breeding of cannabis plants has expanded and diversified as commercial and therapeutic markets develop. Some growers in the U.S. succeeded in lowering the proportion of CBD-to-THC to accommodate customers who preferred varietals that were more mind-altering due to the higher THC and lower CBD content. Hemp is classified as any part of the cannabis plant containing no more than 0.3% THC in dry weight form (not liquid or extracted form).